Market leadership Leverage LivaNova's global footprint and leadership in cardiopulmonary and neuromodulation to position complementary devices, services, or support solutions that expand installed base across hospitals in over 100 countries.

Scaleable manufacturing With Q2 earnings highlighting investments in manufacturing capacity and IT infrastructure, offer systems, ERP integration, and digital manufacturing optimization services to help sustain growth and reduce cycle times.

Clinical and economic value Highlight value-based selling opportunities by aligning products with both clinical outcomes and total cost of ownership to appeal to hospital procurement teams seeking cost-effective, patient-turnaround solutions.

Digital ecosystem Target opportunities in analytics, data integration, and software-enabled care pathways given LivaNova’s tech stack and emphasis on continuous delivery, offering solutions that enhance monitoring, performance tracking, and post-market insights.

Strategic partnerships Propose collaboration with major financial and services stakeholders (e.g., insurers, hospital networks, and distributors) to expand adoption, support capital equipment cycles, and optimize reimbursement pathways for neuromodulation and cardiopulmonary devices.